Preferred Label : etidronic acid;

MeSH definition : A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.;

MeSH synonym : hydroxyethylidene diphosphonic acid; diphosphonic acid, hydroxyethylidene; (1-hydroxyethylene)diphosphonic acid;

MeSH hyponym : Etidronate Disodium; xidifon; didronel; dicalcium etidronate; etidronate; Etidronate, Tetrapotassium Salt; 1-Hydroxyethane-1,1-Diphosphonate; 1 Hydroxyethane 1,1 Diphosphonate; 1-Hydroxyethylidene-1,1-Bisphosphonate; 1 Hydroxyethylidene 1,1 Bisphosphonate; EHDP; 1,1-hydroxyethylenediphosphonate; 1,1 hydroxyethylenediphosphonate; HEDP; Hydroxyethanediphosphonate; Ethanehydroxyphosphate; Ethanehydroxydiphosphonate; Phosphonic acid, (1-hydroxyethylidene)bis-, disodium salt; Sodium Etidronate; Etidronate, Sodium; Disodium 1-Hydroxyethylene Diphosphonate; 1-Hydroxyethylene Diphosphonate, Disodium; Diphosphonate, Disodium 1-Hydroxyethylene; Disodium 1 Hydroxyethylene Diphosphonate; Disodium Etidronate; Etidronate, Disodium; HEDSPA; Etidronate, Dicalcium; Dicalcium EHDP; EHDP, Dicalcium; Xydiphone; Xidiphon; Salt Etidronate, Tetrapotassium; Tetrapotassium Salt Etidronate; (1-hydroxyethylene)diphosphonic acid, Tetrapotassium Salt;

MeSH Related Number : etidronate, tetrapotassium salt; etidronate disodium; 2809-21-4 (Etidronic acid); 7414-83-7 (Etidronate disodium); etidronate; 14860-53-8; M16PXG993G;

Registry Number MeSH : 2809-21-4;

Related CAS MeSH : 14860-53-8 (Etidronate, tetrapotassium salt); M16PXG993G (Etidronate disodium); M2F465ROXU (Etidronate);

Wikipedia link : https://en.wikipedia.org/wiki/Etidronic acid;

Codes EINECS : 220-552-8;

Is substance : O;

UNII : M2F465ROXU;

InChIKey : DBVJJBKOTRCVKF-UHFFFAOYSA-N;

Details


Main resources

You can consult :

A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.

https://www.cochrane.org/fr/CD003376/MUSKEL_letidronate-previent-il-les-fractures-causees-par-losteoporose-chez-les-femmes-post-menopausees
2024
false
true
false
United Kingdom
France
etidronic acid
treatment outcome
review of literature
french abstract
osteoporotic fractures
postmenopause

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=60501119
2012
France
summary of product characteristics
package leaflet
etidronic acid
tablets

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-05/etidronate_mylan_-_ct-10632.pdf
http://www.has-sante.fr/portail/jcms/c_1051917/etidronate-mylan
2011
France
French
evaluation of the transparency committee
etidronic acid
administration, oral
bone density conservation agents
etidronic acid
osteitis deformans
hypercalcemia
osteoporosis, postmenopausal
treatment outcome
risk assessment
drugs, generic
bone resorption

---
http://www.has-sante.fr/portail/jcms/c_1051914/etidronate-sandoz
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-05/etidronate_sandoz_-_ct-10631.pdf
2011
France
French
evaluation of the transparency committee
etidronic acid
administration, oral
bone density conservation agents
etidronic acid
treatment outcome
risk assessment
drugs, generic
osteoporosis, postmenopausal
bone resorption

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64566299
2010
France
French
calcium carbonate
calcium carbonate
bone density conservation agents
bone density conservation agents
cholecalciferol
cholecalciferol
vitamins
vitamins
administration, oral
osteoporosis, postmenopausal
spinal fractures
hip fractures
drug interactions
pregnancy
breast feeding
risedronic acid, calcium and colecalciferol, sequential
drug evaluation, preclinical
hemipenta hydrate risedronate monosodium
hemipenta hydrate risedronate monosodium
etidronic acid
summary of product characteristics
package leaflet

---
http://www.has-sante.fr/portail/jcms/c_1032355/didronel-acide-etidronique-bisphosphonate
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-01/didronel_-_ct-8007.pdf
2010
France
French
Adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
administration, oral
etidronic acid
bone density conservation agents
etidronic acid
osteitis deformans
osteoporosis, postmenopausal
hypercalcemia
bone resorption
bone resorption
glucocorticoids
Hypercalcaemia of malignancy
treatment outcome
etidronic acid
bone density conservation agents
femoral neck fractures
spinal fractures
insurance, health, reimbursement
evaluation of the transparency committee
guidelines for drug use
hypercalcemia
neoplasms

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-01/didronel_-_ct-8007.pdf
http://www.has-sante.fr/portail/jcms/c_1016649/didronel
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-08/didronel_ct_8007.pdf
2010
France
French
English
Adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
etidronic acid
administration, oral
bone density conservation agents
etidronic acid
osteitis deformans
adult
hypercalcemia
osteoporosis, postmenopausal
bone resorption
bone resorption
glucocorticoids
treatment outcome
etidronic acid
bone density conservation agents
evaluation of the transparency committee

---
http://www.lecrat.eu/?s=Ris%C3%A9dronate
2009
France
French
pregnancy
etidronic acid
bone density conservation agents
risedronic acid
hemipenta hydrate risedronate monosodium
drug information

---
http://www.lecrat.eu/?s=Etidronate
2009
France
French
pregnancy
etidronic acid
bone density conservation agents
etidronic acid
drug information

---
Nous contacter.
02/06/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.